Related Experiment Video
Updated: Jun 21, 2026

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
Published on: June 18, 2018
Calbindin-1 association and Parkinson's disease
A I Soto-Ortolaza1, B Behrouz, C Wider
1Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, USA.
Background And Purpose:
Calcium levels have been proposed to play an important role in the selective vulnerability of nigrostriatal dopaminergic neurons in Parkinson's disease (PD). Recently, an association was reported between the calcium buffer, calbindin (rs1805874) and risk of PD in a Japanese patient-control series.
Methods:
We genotyped rs1805874 in four independent Caucasian patient-control series (1543 PD patients, 1771 controls).
Results:
There was no evidence of an association between rs1805874 and disease risk in individual populations or in the combined series (odds ratio: 1.04, 95% CI: 0.82-1.31, P = 0.74).
Discussion:
Our study shows there is no association between rs1805874 and risk for PD in four Caucasian populations. This suggests the effect of calbindin on PD risk displays population specificity.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Parkinson Disease l: Introduction
Neural Regulation
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Parkinson's Disease: Overview
Lysosomal Hydrolases
